Accordingly, enhanced IL-6 signaling in serum and tissues has been found in rheumatoid arthritis, systemic lupus erythematosus, and RR-MS patients (Linker-Israeli et al., 1991; Maimone et al., 1997; Hirano, 1998). This evidence concerns the gene IL6 and systemic lupus erythematosus.